Targeting galectins in T cell-based immunotherapy within tumor microenvironment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting galectins in T cell-based immunotherapy within tumor microenvironment
Authors
Keywords
Galectin, Tumor immunotherapy, Tumor microenvironment, T cell, Immune checkpoint therapy
Journal
LIFE SCIENCES
Volume 277, Issue -, Pages 119426
Publisher
Elsevier BV
Online
2021-03-28
DOI
10.1016/j.lfs.2021.119426
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The expression of Galectin-3 in breast cancer and its association with metastatic disease: a systematic review of the literature
- (2021) Ioannis Boutas et al. MOLECULAR BIOLOGY REPORTS
- Inhibition of galectin‐3 augments the antitumor efficacy of PD‐L1 blockade in non‐small‐cell lung cancer
- (2021) Hongxin Zhang et al. FEBS Open Bio
- The role of Tim‐3/Galectin‐9 pathway in T‐cell function and prognosis of patients with human papilloma virus‐associated cervical carcinoma
- (2021) Zhifang Chen et al. FASEB JOURNAL
- Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy
- (2021) Riyao Yang et al. Nature Communications
- Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases
- (2020) Heng-Yi Chen et al. JOURNAL OF IMMUNOLOGY
- Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels
- (2020) Adrian M. Seifert et al. ONCOGENE
- A Synthetic Tetramer of Galectin-1 and Galectin-3 Amplifies Pro-apoptotic Signaling by Integrating the Activity of Both Galectins
- (2020) Shaheen A. Farhadi et al. Frontiers in Chemistry
- BRAF inhibition curtails IFN‐gamma‐inducible PD‐L1 expression and upregulates the immunoregulatory protein galectin‐1 in melanoma cells
- (2020) Patryk Górniak et al. Molecular Oncology
- Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy
- (2020) Xiaodong Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Animal Lectin Galectin-8 Promotes Cytokine Expression and Metastatic Tumor Growth in Mice
- (2020) Hadas Shatz-Azoulay et al. Scientific Reports
- High Galectin-7 and Low Galectin-8 Expression and the Combination of both are Negative Prognosticators for Breast Cancer Patients
- (2020) Anna Trebo et al. Cancers
- Galectin-8 Favors VEGF-Induced Angiogenesis: In Vitro Study in Human Umbilical Vein Endothelial Cells and In Vivo Study in Chick Chorioallantoic Membrane
- (2020) LENKA VARINSKÁ et al. ANTICANCER RESEARCH
- Galectin-3 expression and secretion by tumor-associated macrophages in hypoxia promotes breast cancer progression
- (2020) Lei Wang et al. BIOCHEMICAL PHARMACOLOGY
- Galectin-3 is modulated in pancreatic cancer cells under hypoxia and nutrient deprivation
- (2020) Antônio F. da Silva Filho et al. BIOLOGICAL CHEMISTRY
- Galectin-9 Induced by Dietary Prebiotics Regulates Immunomodulation to Reduce Atopic Dermatitis Symptoms in 1-Chloro-2,4-Dinitrobenzene (DNCB)-Treated NC/Nga Mice
- (2020) Jeong A Kim et al. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Proteomic Analysis of Metastasis-Specific Biomarkers in Pancreatic Cancer: Galectin-1 Plays an Important Metastatic Role in Pancreatic Cancer
- (2020) Chun-Liang Tung et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Low Galectin-3 Expression Level in Primary Tumors Is Associated with Metastasis in T1 Lung Adenocarcinoma
- (2020) Ming-Wei Kao et al. Journal of Clinical Medicine
- Galectin-8 Enhances T cell Response by Promotion of Antigen Internalization and Processing
- (2020) Cecilia Arahí Prato et al. iScience
- Novel benzimidazole-triazole hybrids as apoptosis inducing agents in lung cancer: Design, synthesis, 18F-radiolabeling & galectin-1 inhibition studies
- (2020) Nerella Sridhar Goud et al. BIOORGANIC CHEMISTRY
- Hypoxia contributes to galectin-3 expression in renal carcinoma cells
- (2020) Xin Gu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Serum galectin‐3 as a biomarker for screening, early diagnosis, prognosis and therapeutic effect evaluation of pancreatic cancer
- (2020) Nan Yi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
- (2020) Fei Kong et al. PeerJ
- Transforming growth factor beta type 1 (TGF-β) and hypoxia-inducible factor 1 (HIF-1) transcription complex as master regulators of the immunosuppressive protein galectin-9 expression in human cancer and embryonic cells
- (2020) Anette Teo Hansen Selnø et al. Aging-US
- Binding of a Soluble meso-Tetraarylporphyrin to Human Galectin-7 Induces Oligomerization and Modulates Its Pro-Apoptotic Activity
- (2020) Yossef López de los Santos et al. BIOCHEMISTRY
- Ligand-Receptor Interactions of Galectin-9 and VISTA Suppress Human T Lymphocyte Cytotoxic Activity
- (2020) Inna M. Yasinska et al. Frontiers in Immunology
- Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome
- (2020) Carolina Tiraboschi et al. Journal for ImmunoTherapy of Cancer
- Proteomic identification of tumor- and metastasis-associated galectin-1 in claudin-low breast cancer
- (2020) Kassondra Balestrieri et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
- (2019) Xianjie Jiang et al. Molecular Cancer
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Galectin 4 is a biomarker for early recurrence and death after surgical resection for pancreatic ductal adenocarcinoma
- (2019) Dingyuan Hu et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Tim-3/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients
- (2019) Emeric Limagne et al. OncoImmunology
- Lack of galectin-1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma model
- (2019) Tamara Potikha et al. FASEB JOURNAL
- An orally active galectin-3 antagonist inhibits lung adenocarcinoma growth and augments response to PD-L1 blockade
- (2019) Lynda Vuong et al. CANCER RESEARCH
- Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy: The Galectin-3 Signature in NSCLCs
- (2019) Carlo Capalbo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Galectin-1 Inhibition Induces Cell Apoptosis Through Dual Suppression of CXCR4 and Ras Pathways in Human Malignant Peripheral Nerve Sheath Tumors
- (2019) Tsung-Chieh Shih et al. NEURO-ONCOLOGY
- Combination of CTLA-4 and PD-1 blockers for treatment of cancer
- (2019) Anand Rotte JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels
- (2019) Kostandinos Sideras et al. Scientific Reports
- Pectasol‐C Modified Citrus Pectin targets Galectin‐3‐induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids
- (2019) Ghamartaj Hossein et al. Cancer Medicine
- Selective effects of ginseng pectins on galectin-3-mediated T cell activation and apoptosis
- (2019) Huiting Xue et al. CARBOHYDRATE POLYMERS
- Possible therapeutic applicability of galectin-9 in cutaneous T-cell lymphoma
- (2019) Rina Nakajima et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Unraveling LGALS1 as a Potential Immune Checkpoint and a Predictor of the Response to Anti-PD1 Therapy in Clear Cell Renal Carcinoma
- (2019) Yan Li et al. PATHOLOGY & ONCOLOGY RESEARCH
- Galectin-9: A Predictive Biomarker Negatively Regulating Immune Response in Glioma Patients
- (2019) Tingyu Liang et al. World Neurosurgery
- Galectin-1–driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance
- (2019) Dhanya K. Nambiar et al. JOURNAL OF CLINICAL INVESTIGATION
- Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells
- (2019) Zoe Leung et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- EXTH-48. GALECTIN-1 INHIBITION SENSITIZES RADIATION TREATMENT IN A PRE-CLINICAL MODEL OF GLIOBLASTOMA
- (2019) Fraser Henderson et al. NEURO-ONCOLOGY
- Pleiotropic Effects of Modified Citrus Pectin
- (2019) Isaac Eliaz et al. Nutrients
- Molecular and immune correlates of TIM-3 (HAVCR2) and galectin 9 (LGALS9) mRNA expression and DNA methylation in melanoma
- (2019) Tobias A. W. Holderried et al. Clinical Epigenetics
- Galectin-3 Interacts with C/EBPβ and Upregulates Hyaluronan-Mediated Motility Receptor Expression in Gastric Cancer
- (2019) Hyeon-Gu Kang et al. MOLECULAR CANCER RESEARCH
- The Structural Biology of Galectin-Ligand Recognition: Current Advances in Modeling Tools, Protein Engineering, and Inhibitor Design
- (2019) Carlos P. Modenutti et al. Frontiers in Chemistry
- Galectin-1 Restores Immune Tolerance to Liver Transplantation Through Activation of Hepatic Stellate Cells
- (2018) Zhi-Jun Jiang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Targeting Galectin-1 Impairs Castration-Resistant Prostate Cancer Progression and Invasion
- (2018) Tsung-Chieh Shih et al. CLINICAL CANCER RESEARCH
- Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives
- (2018) Kamil Wdowiak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment
- (2018) Samaresh Sau et al. JOURNAL OF CONTROLLED RELEASE
- Galectin-7 promotes proliferation and Th1/2 cells polarization toward Th1 in activated CD4+ T cells by inhibiting The TGFβ/Smad3 pathway
- (2018) Zhenlong Luo et al. MOLECULAR IMMUNOLOGY
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- TCR Signaling: Mechanisms of Initiation and Propagation
- (2018) Adam H. Courtney et al. TRENDS IN BIOCHEMICAL SCIENCES
- Molecular Mechanisms Underlying the Role of Galectin-8 as a Regulator of Cancer Growth and Metastasis
- (2018) Yaron Vinik et al. TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY
- Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
- (2018) Flávia Castro et al. Frontiers in Immunology
- Anti-CTLA-4 based therapy elicits humoral immunity to galectin-3 in patients with metastatic melanoma
- (2018) Xinqi Wu et al. OncoImmunology
- Effect of anthracycline and taxane on the expression of programmed cell death ligand-1 and galectin-9 in triple-negative breast cancer
- (2018) Hye Kyoung Yoon et al. PATHOLOGY RESEARCH AND PRACTICE
- Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity
- (2018) Enrique Corapi et al. Frontiers in Immunology
- Cancer immunoediting and resistance to T cell-based immunotherapy
- (2018) Jake S. O’Donnell et al. Nature Reviews Clinical Oncology
- Novel polysaccharide binding to the N-terminal tail of galectin-3 is likely modulated by proline isomerization
- (2017) Michelle C Miller et al. GLYCOBIOLOGY
- Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis
- (2017) Hyosun Cho et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models
- (2017) Nathan Koonce et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Regulatory T Cell–Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9
- (2017) Shravan Madireddi et al. JOURNAL OF IMMUNOLOGY
- A Novel Galectin-1 Inhibitor Discovered through One-Bead Two-Compound Library Potentiates the Antitumor Effects of Paclitaxel in vivo
- (2017) Tsung-Chieh Shih et al. MOLECULAR CANCER THERAPEUTICS
- The benefits of immunotherapy combinations
- (2017) Charles Schmidt NATURE
- Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance
- (2017) Donnele Daley et al. NATURE MEDICINE
- Inverse correlation between galectin-4 and TTF-1 in lung adenocarcinoma
- (2017) Kieko Hara et al. VIRCHOWS ARCHIV
- Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment
- (2017) Rachel S. Riley et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration
- (2017) Monica Gordon-Alonso et al. Nature Communications
- Galectin-3 induced by hypoxia promotes cell migration in thyroid cancer cells
- (2017) Jiaojiao Zheng et al. Oncotarget
- Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation
- (2017) Sofia Nascimento dos Santos et al. Oncotarget
- The N-terminal tail coordinates with carbohydrate recognition domain to mediate galectin-3 induced apoptosis in T cells
- (2017) Huiting Xue et al. Oncotarget
- Combined Anti-VEGF and Anti–CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes
- (2017) Xinqi Wu et al. Cancer Immunology Research
- Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy
- (2017) Matthias Van Woensel et al. Scientific Reports
- Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy
- (2016) J. M. Pitt et al. ANNALS OF ONCOLOGY
- Roles of Galectin-7 in Cancer
- (2016) Manpreet Kaur et al. Asian Pacific Journal of Cancer Prevention
- Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells
- (2016) Peter P. Ruvolo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Galectin-1 inhibitors and their potential therapeutic applications: a patent review
- (2016) Helen Blanchard et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
- (2016) Jonathan M. Pitt et al. IMMUNITY
- Galectin-9 modulates immunity by promoting Th2/M2 differentiation and impacts survival in patients with metastatic melanoma
- (2016) Elizabeth Ann L. Enninga et al. MELANOMA RESEARCH
- Thiodigalactoside shows antitumour activity by beta-galactoside-binding protein and regulatory T cells inhibition in oral squamous cell carcinoma
- (2016) S Aggarwal et al. ORAL DISEASES
- Correction to: ‘The Warburg Effect: How Does it Benefit Cancer Cells?’
- (2016) Maria V. Liberti et al. TRENDS IN BIOCHEMICAL SCIENCES
- Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments
- (2016) Ana Carolina Ferreira Cardoso et al. Frontiers in Oncology
- Galectin-1-Induced Autophagy Facilitates Cisplatin Resistance of Hepatocellular Carcinoma
- (2016) Yu-Chi Su et al. PLoS One
- Galectin-8 promotes regulatory T-cell differentiation by modulating IL-2 and TGFβ signaling
- (2015) James F Sampson et al. IMMUNOLOGY AND CELL BIOLOGY
- G3-C12 Peptide Reverses Galectin-3 from Foe to Friend for Active Targeting Cancer Treatment
- (2015) Wei Sun et al. MOLECULAR PHARMACEUTICS
- T cell exclusion, immune privilege, and the tumor microenvironment
- (2015) J. A. Joyce et al. SCIENCE
- Apoptosis and anergy of T cell induced by pancreatic stellate cells-derived galectin-1 in pancreatic cancer
- (2015) Dong Tang et al. TUMOR BIOLOGY
- Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression
- (2015) Dong Tang et al. TUMOR BIOLOGY
- T-cell exhaustion in the tumor microenvironment
- (2015) Y Jiang et al. Cell Death & Disease
- Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis
- (2015) Carrie A Duckworth et al. Oncotarget
- Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
- (2015) T. Kouo et al. Cancer Immunology Research
- Characterization of thein vivoimmune network of IDO, tryptophan metabolism, PD-L1, andCTLA-4in circulating immune cells in melanoma
- (2015) I Chevolet et al. OncoImmunology
- Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature
- (2015) Stefanie Linch et al. Journal for ImmunoTherapy of Cancer
- Delivery and therapeutic potential of human granzyme B
- (2015) Florian C. Kurschus et al. IMMUNOLOGICAL REVIEWS
- Hypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis
- (2015) Joana T. de Oliveira et al. PLoS One
- Galectin-7 is epigenetically-regulated tumor suppressor in gastric cancer
- (2015) Seok-Jun Kim et al. Oncotarget
- Galectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma
- (2014) Zhixiong Cai et al. CANCER SCIENCE
- Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
- (2014) Diego O. Croci et al. CELL
- A Short Treatment with Galactomannan GM-CT-01 Corrects the Functions of Freshly Isolated Human Tumor-Infiltrating Lymphocytes
- (2014) N. Demotte et al. CLINICAL CANCER RESEARCH
- OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis
- (2014) Lucile Astorgues-Xerri et al. EUROPEAN JOURNAL OF CANCER
- Galectin-3 in angiogenesis and metastasis
- (2014) T. Funasaka et al. GLYCOBIOLOGY
- Galectin-9-CD44 Interaction Enhances Stability and Function of Adaptive Regulatory T Cells
- (2014) Chuan Wu et al. IMMUNITY
- The effects of galectin-1 on the gene expression of the transcription factors TBX21, GATA-3, FOXP3 and RORC
- (2014) V. D. Yakushina et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Galectin-3 Up-Regulation in Hypoxic and Nutrient Deprived Microenvironments Promotes Cell Survival
- (2014) Rafael Yamashita Ikemori et al. PLoS One
- Acidity Generated by the Tumor Microenvironment Drives Local Invasion
- (2013) V. Estrella et al. CANCER RESEARCH
- Galectin-3 negatively regulates the frequency and function of CD4+CD25+Foxp3+regulatory T cells and influences the course ofLeishmania majorinfection
- (2013) Marise L. Fermino et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Phosphorylation and externalization of galectin-4 is controlled by Src family kinases
- (2013) Hiroko Ideo et al. GLYCOBIOLOGY
- Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity
- (2013) Tina Verschuere et al. INTERNATIONAL JOURNAL OF CANCER
- The Inhibitory Effects of a Rhamnogalacturonan Ι (RG-I) Domain from Ginseng Pectin on Galectin-3 and Its Structure-Activity Relationship
- (2013) Xiaoge Gao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Abrogation of galectin-4 expression promotes tumorigenesis in colorectal cancer
- (2013) Seung Won Kim et al. CELLULAR ONCOLOGY
- Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
- (2012) Koichi Ito et al. CANCER AND METASTASIS REVIEWS
- Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer
- (2012) Lauren J. Bayne et al. CANCER CELL
- Oncogenic Kras-Induced GM-CSF Production Promotes the Development of Pancreatic Neoplasia
- (2012) Yuliya Pylayeva-Gupta et al. CANCER CELL
- Combination effect of PectaSol and Doxorubicin on viability, cell cycle arrest and apoptosis in DU-145 and LNCaP prostate cancer cell lines
- (2012) Najmeh Tehranian et al. CELL BIOLOGY INTERNATIONAL
- Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma
- (2012) Diego O. Croci et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Redundant and Antagonistic Functions of Galectin-1, -3, and -8 in the Elicitation of T Cell Responses
- (2012) M. V. Tribulatti et al. JOURNAL OF IMMUNOLOGY
- Galectin-1 Triggers an Immunoregulatory Signature in Th Cells Functionally Defined by IL-10 Expression
- (2012) F. Cedeno-Laurent et al. JOURNAL OF IMMUNOLOGY
- Galectin-3 in preneoplastic lesions of glioma
- (2012) Nguyen Huy Binh et al. JOURNAL OF NEURO-ONCOLOGY
- Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion
- (2012) Manu Rangachari et al. NATURE MEDICINE
- The three main stumbling blocks for anticancer T cells
- (2012) Lukas Baitsch et al. TRENDS IN IMMUNOLOGY
- Hypoxia Promotes Tumor Growth in Linking Angiogenesis to Immune Escape
- (2012) Salem Chouaib et al. Frontiers in Immunology
- Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress
- (2011) Koichi Ito et al. ANGIOGENESIS
- Treatment of prostate carcinoma with (Galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates
- (2011) Yang Yang et al. BIOMATERIALS
- Activation of Human T-Helper/Inducer Cell, T-Cytotoxic Cell, B-Cell, and Natural Killer (NK)-Cells and induction of Natural Killer Cell Activity against K562 Chronic Myeloid Leukemia Cells with Modified Citrus Pectin
- (2011) Cheppail Ramachandran et al. BMC Complementary and Alternative Medicine
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Serum Galectin-2, -4, and -8 Are Greatly Increased in Colon and Breast Cancer Patients and Promote Cancer Cell Adhesion to Blood Vascular Endothelium
- (2011) H. Barrow et al. CLINICAL CANCER RESEARCH
- Galectin-1 research in T cell immunity: Past, present and future
- (2011) Filiberto Cedeno-Laurent et al. CLINICAL IMMUNOLOGY
- Galectin-2 expression is dependent on the rs7291467 polymorphism and acts as an inhibitor of arteriogenesis
- (2011) Anja M. van der Laan et al. EUROPEAN HEART JOURNAL
- Lowered expression of galectin-2 is associated with lymph node metastasis in gastric cancer
- (2011) Ji-Han Jung et al. JOURNAL OF GASTROENTEROLOGY
- The Adaptor Protein Bam32 in Human Dendritic Cells Participates in the Regulation of MHC Class I-Induced CD8 + T Cell Activation
- (2011) Daniela Ortner et al. JOURNAL OF IMMUNOLOGY
- GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death
- (2010) M. J. Streetly et al. BLOOD
- Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells
- (2010) Xu-Yun Zhao et al. CARCINOGENESIS
- Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response
- (2010) Anna I. Markowska et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibiting Tumor Growth by Targeting Tumor Vasculature with Galectin-1 Antagonist Anginex Conjugated to the Cytotoxic Acylfulvene, 6-Hydroxylpropylacylfulvene
- (2009) Ruud P. M. Dings et al. BIOCONJUGATE CHEMISTRY
- Galectin-2 Suppresses Contact Allergy by Inducing Apoptosis in Activated CD8+ T Cells
- (2009) K. Loser et al. JOURNAL OF IMMUNOLOGY
- Cross-Linking of GM1 Ganglioside by Galectin-1 Mediates Regulatory T Cell Activity Involving TRPC5 Channel Activation: Possible Role in Suppressing Experimental Autoimmune Encephalomyelitis
- (2009) J. Wang et al. JOURNAL OF IMMUNOLOGY
- The significance of Treg cells in defective tumor immunity
- (2008) Agata Kosmaczewska et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Structural Features of Galectin-9 and Galectin-1 That Determine Distinct T Cell Death Pathways
- (2008) Shuguang Bi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Galectin-Inhibitory Thiodigalactoside Ester Derivatives Have Antimigratory Effects in Cultured Lung and Prostate Cancer Cells
- (2008) Tamara Delaine et al. JOURNAL OF MEDICINAL CHEMISTRY
- Galectin-4 Controls Intestinal Inflammation by Selective Regulation of Peripheral and Mucosal T Cell Apoptosis and Cell Cycle
- (2008) Daniela Paclik et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More